BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qi X, Yang M, Stenberg J, Dey R, Fogwe L, Alam MS, Kimchi ET, Staveley-O'Carroll KF, Li G. Gut microbiota mediated molecular events and therapy in liver diseases. World J Gastroenterol 2020; 26(48): 7603-7618 [PMID: 33505139 DOI: 10.3748/wjg.v26.i48.7603]
URL: https://www.wjgnet.com/1007-9327/full/v26/i48/7603.htm
Number Citing Articles
1
Ming Yang, Lea Khoukaz, Xiaoqiang Qi, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and TreatmentBiomedicines 2021; 9(12): 1893 doi: 10.3390/biomedicines9121893
2
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalisFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
3
Wenyu Luo, Shiqi Guo, Yang Zhou, Jingwen Zhao, Mengyao Wang, Lixuan Sang, Bing Chang, Bingyuan Wang. Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and TherapyFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.873160
4
Amedeo Amedei, Stefano Gitto, Claudia Campani, Fabio Marra. Probiotics2022; : 467 doi: 10.1016/B978-0-323-85170-1.00003-8
5
Miguel Angel Martinez, Sandra Franco. Impact of COVID‐19 in Liver Disease Progression Hepatology Communications 2021; 5(7): 1138 doi: 10.1002/hep4.1745
6
Milena Peruhova, Monika Peshevska-Sekulovska, Tsvetelina Velikova. Interactions between human microbiome, liver diseases, and immunosuppression after liver transplantWorld Journal of Immunology 2021; 11(2): 11-16 doi: 10.5411/wji.v11.i2.11